Clinical Trial

Sternocleidomastoid Thickness in Sarcopenia

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 25, 2025 (before its estimated February 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
In order to prevent sarcopenia in intensive care patients and to guide nutritional therapy, evaluation of muscle thickness with ultrasonography is a modern, simple and non-invasive procedure routinely performed by Anesthesiology and Reanimation specialists. Sarcopenia in intensive care patients has been demonstrated in many studies. It has been studied that routine examination of changes in rectus femoris muscle thickness by ultrasonography is a predictor of sarcopenia. However, the muscles in the neck region, such as the sternocleidomastoid muscle, which are easy to examine, have not been studied very well. There is no study in the literature with the sternocleidomastoid muscle. For this reason, we decided to examine the relationship of sternocleidomastoid muscle thickness with patient characteristics, treatments, feeding route and type, feeding time, length of stay in intensive care unit, as in routine measurements of rectus femoris muscle thickness by ultrasonography.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-06-23; most recent amendment 2025-06-19.
Status change: Recruiting → Not Yet Recruiting 2024-11-20
Status change: Not Yet Recruiting → Recruiting 2023-07-28
Trial Details
NCT Number NCT05928845
Lead Sponsor Namik Kemal University
Conditions Sarcopenia
Enrollment 80 participants
Start Date 2025-09-01
Primary Completion 2026-02-01 (estimated)
Study Completion 2026-02-15 (estimated)
Updated on ClinicalTrials.gov 2025-06-25